BCAL Diagnostics Limited (AU:BDX) has released an update.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
BCAL Diagnostics Limited announces the quotation of 3 million fully paid ordinary shares on the Australian Securities Exchange (ASX), following shareholder approval at the recent Annual General Meeting. This move marks a significant step for the company, potentially attracting investor interest and impacting stock market dynamics.
For further insights into AU:BDX stock, check out TipRanks’ Stock Analysis page.